PharmaCielo Ltd. (PCLO.V)
CAD 0.09
(-10.0%)
CAD 0.09
(-10.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 2.55 Million CAD | -78.31% |
| 2022 | 11.77 Million CAD | 43.49% |
| 2021 | 8.2 Million CAD | 93.91% |
| 2020 | 4.23 Million CAD | 196.89% |
| 2019 | 1.42 Million CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 3.47 Million CAD | 36.01% |
| 2024 Q2 | 4.34 Million CAD | 25.0% |
| 2023 Q3 | 15.65 Million CAD | 7.32% |
| 2023 Q4 | 2.55 Million CAD | -83.69% |
| 2023 FY | 2.55 Million CAD | -78.31% |
| 2023 Q1 | 13.15 Million CAD | 11.76% |
| 2023 Q2 | 14.58 Million CAD | 10.91% |
| 2022 FY | 11.77 Million CAD | 43.49% |
| 2022 Q2 | 9.33 Million CAD | 20.68% |
| 2022 Q1 | 7.73 Million CAD | -5.68% |
| 2022 Q4 | 11.77 Million CAD | 10.72% |
| 2022 Q3 | 10.63 Million CAD | 13.86% |
| 2021 Q1 | 3.98 Million CAD | -5.86% |
| 2021 FY | 8.2 Million CAD | 93.91% |
| 2021 Q4 | 8.2 Million CAD | 112.09% |
| 2021 Q3 | 3.86 Million CAD | 1.81% |
| 2021 Q2 | 3.79 Million CAD | -4.6% |
| 2020 Q2 | 1.3 Million CAD | -3.77% |
| 2020 Q4 | 4.23 Million CAD | 237.57% |
| 2020 FY | 4.23 Million CAD | 196.89% |
| 2020 Q1 | 1.35 Million CAD | -5.01% |
| 2020 Q3 | 1.25 Million CAD | -3.78% |
| 2019 Q3 | 1.25 Million CAD | -3.15% |
| 2019 Q2 | 1.29 Million CAD | -2.27% |
| 2019 Q1 | 1.32 Million CAD | 0.0% |
| 2019 FY | 1.42 Million CAD | 0.0% |
| 2019 Q4 | 1.42 Million CAD | 13.81% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2018 Q4 | - CAD | 0.0% |
| 2018 FY | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 583.58 Thousand CAD | -337.538% |
| CanadaBis Capital Inc. | 5.91 Million CAD | 56.841% |
| Decibel Cannabis Company Inc. | 32.34 Million CAD | 92.106% |
| Delivra Health Brands Inc. | 1.78 Million CAD | -43.048% |
| Entourage Health Corp. | 5.79 Million CAD | 55.923% |
| Lifeist Wellness Inc. | 868.65 Thousand CAD | -193.95% |
| Cannara Biotech Inc. | 39.73 Million CAD | 93.574% |
| Medicure Inc. | 229 Thousand CAD | -1015.028% |
| Rubicon Organics Inc. | - CAD | -Infinity% |
| BioSyent Inc. | 1.03 Million CAD | -146.057% |
| Voyageur Pharmaceuticals Ltd. | 40 Thousand CAD | -6283.533% |